Abliva AB (publ)
NEVPF · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $12 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $25 | $7 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $27 | $20 | $0 | $0 |
| Operating Expenses | $27 | $20 | $26 | $19 |
| Operating Income | -$27 | -$20 | -$26 | -$19 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $0 | -$0 | -$0 |
| Pre-Tax Income | -$26 | -$20 | -$26 | -$18 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$26 | -$20 | -$26 | -$18 |
| % Margin | – | – | – | – |
| EPS | -0.021 | -0.016 | -0.02 | -0.017 |
| % Growth | -35.5% | 24% | -18.6% | – |
| EPS Diluted | -0.021 | -0.016 | -0.02 | -0.017 |
| Weighted Avg Shares Out | 1,259 | 1,259 | 1,259 | 1,056 |
| Weighted Avg Shares Out Dil | 1,259 | 1,259 | 1,259 | 1,056 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$26 | -$19 | -$25 | -$18 |
| % Margin | – | – | – | – |